Last Thursday, Allergan announced that its third quarter profit rose by eight percent for eye care and Botox sales.

The company earned $179 million, which marks an increase from $165.4 million. Revenue rose by four percent from $1.1 billion to $1.14 billion.

Not including charges, the company said it earned 70 cents per share.

Experts forecasted a profit of 69 cents per share on a revenue of $1.08 billion.
Sales of Botox wrinkle treatments rose by 3 percent to $327.8 million.